SCHEMBL6554448

SCHEMBL6554448

Cc1cccc(-c2c(-c3cncn3C)c3nnnn3c3ccc(C(N)c4ccc(Cl)cc4)cc23)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FNTA P49354 7/20 0.41
FNTB P49356 7/20 0.41
PGGT1B P53609 2/20 0.41
IDO1 P14902 2/20 0.38
POLB P06746 2/20 0.34
TP53 P04637 2/20 0.34
MAPT P10636 4/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
CYP3A4 P08684 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7167060 0.93 FNTA (0.47) FNTAFNTBPGGT1BIDO1
SCHEMBL7854078 0.83 IDO1 (0.46) FNTAFNTBPGGT1BIDO1
SCHEMBL7191102 0.81 FNTA (0.47) FNTAFNTBPGGT1BIDO1
SCHEMBL7645793 0.76 FNTA (0.47) FNTAFNTBPGGT1BIDO1MAPK1
SCHEMBL5221738 0.73 FNTA (0.58) FNTAFNTBPGGT1BIDO1
SCHEMBL7645087 0.71 IDO1 (0.44) FNTAFNTBPGGT1BIDO1TP53
SCHEMBL2177983 0.70 FNTA (0.54) FNTAFNTBPGGT1BIDO1KCNH2
SCHEMBL7855700 0.70 IDO1 (0.47) FNTAFNTBPGGT1BIDO1
SCHEMBL6556871 0.69 IDO1 (0.46) FNTAFNTBPGGT1BIDO1
SCHEMBL7854629 0.67 FNTA (0.54) FNTAFNTBPGGT1BPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1390033-A1 FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR TREATING CACHEXIA JANSSEN PHARMACEUTICA N.V. (BE) 2004-02-25 EP disclosed
EP-1339407-A1 FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE JANSSEN PHARMACEUTICA N.V. (BE) 2003-09-03 EP disclosed
EP-1255537-A2 FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR TREATING BREAST CANCER JANSSEN PHARMACEUTICA N.V. (BE) 2002-11-13 EP disclosed
WO-2002085364-A1 FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR TREATING CACHEXIA JANSSEN PHARMACEUTICA N.V. (BE) 2002-10-31 WO disclosed
WO-2002043733-A1 FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE JANSSEN PHARMACEUTICA N.V. (BE) 2002-06-06 WO disclosed
WO-2001056552-A2 FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR TREATING BREAST CANCER JANSSEN PHARMACEUTICA N.V. (BE) 2001-08-09 WO disclosed